INTRODUCTION: Our objective was to determine which symptoms among long-hauler COVID-19 patients change over time, and how their symptoms compare to another chronic illness group. 278 long-haulers completed two symptom questionnaires at one time point, with one recounting experiences from an average of 21.7 weeks prior. METHODS: We used a comparison group of 502 patients diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Participants completed a standardized symptom questionnaire and a list of additional CDC COVID-19 symptoms. RESULTS: Over time, the long-haulers reported an overall reduction of most symptoms including unrefreshing sleep and post-exertional malaise, but an intensification of neurocognitive symptoms. When compared to ME/CFS, the COVID-19 sample was initially more symptomatic for the immune and orthostatic domains but over time, the long-haulers evidenced significantly less severe symptoms than those with ME/CFS, except in the orthostatic domain. Among the COVID-19 long haulers, several neurocognitive symptoms got worse over time, whereas improvements occurred in most other areas. CONCLUSIONS: These types of differential patterns of symptoms over time might contribute to helping better understand the pathophysiology of those reporting prolonged illness following COVID-19.
INTRODUCTION: Our objective was to determine which symptoms among long-hauler COVID-19 patients change over time, and how their symptoms compare to another chronic illness group. 278 long-haulers completed two symptom questionnaires at one time point, with one recounting experiences from an average of 21.7 weeks prior. METHODS: We used a comparison group of 502 patients diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Participants completed a standardized symptom questionnaire and a list of additional CDC COVID-19 symptoms. RESULTS: Over time, the long-haulers reported an overall reduction of most symptoms including unrefreshing sleep and post-exertional malaise, but an intensification of neurocognitive symptoms. When compared to ME/CFS, the COVID-19 sample was initially more symptomatic for the immune and orthostatic domains but over time, the long-haulers evidenced significantly less severe symptoms than those with ME/CFS, except in the orthostatic domain. Among the COVID-19 long haulers, several neurocognitive symptoms got worse over time, whereas improvements occurred in most other areas. CONCLUSIONS: These types of differential patterns of symptoms over time might contribute to helping better understand the pathophysiology of those reporting prolonged illness following COVID-19.
Authors: Crystal L Park; Beth S Russell; Michael Fendrich; Lucy Finkelstein-Fox; Morica Hutchison; Jessica Becker Journal: J Gen Intern Med Date: 2020-05-29 Impact factor: 5.128
Authors: Liam Townsend; Adam H Dyer; Karen Jones; Jean Dunne; Aoife Mooney; Fiona Gaffney; Laura O'Connor; Deirdre Leavy; Kate O'Brien; Joanne Dowds; Jamie A Sugrue; David Hopkins; Ignacio Martin-Loeches; Cliona Ni Cheallaigh; Parthiban Nadarajan; Anne Marie McLaughlin; Nollaig M Bourke; Colm Bergin; Cliona O'Farrelly; Ciaran Bannan; Niall Conlon Journal: PLoS One Date: 2020-11-09 Impact factor: 3.240
Authors: Hannah E Davis; Gina S Assaf; Lisa McCorkell; Hannah Wei; Ryan J Low; Yochai Re'em; Signe Redfield; Jared P Austin; Athena Akrami Journal: EClinicalMedicine Date: 2021-07-15
Authors: Cuiyan Wang; Riyu Pan; Xiaoyang Wan; Yilin Tan; Linkang Xu; Cyrus S Ho; Roger C Ho Journal: Int J Environ Res Public Health Date: 2020-03-06 Impact factor: 3.390
Authors: Gianpaolo Toscano; Francesco Palmerini; Sabrina Ravaglia; Luigi Ruiz; Paolo Invernizzi; M Giovanna Cuzzoni; Diego Franciotta; Fausto Baldanti; Rossana Daturi; Paolo Postorino; Anna Cavallini; Giuseppe Micieli Journal: N Engl J Med Date: 2020-04-17 Impact factor: 91.245
Authors: Suzanne D Vernon; Sherlyn Funk; Lucinda Bateman; Gregory J Stoddard; Sarah Hammer; Karen Sullivan; Jennifer Bell; Saeed Abbaszadeh; W Ian Lipkin; Anthony L Komaroff Journal: Front Med (Lausanne) Date: 2022-06-23
Authors: Olga A Sukocheva; Rebekah Maksoud; Narasimha M Beeraka; SabbaRao V Madhunapantula; Mikhail Sinelnikov; Vladimir N Nikolenko; Margarita E Neganova; Sergey G Klochkov; Mohammad Amjad Kamal; Donald R Staines; Sonya Marshall-Gradisnik Journal: J Adv Res Date: 2021-11-26 Impact factor: 12.822
Authors: D Castanares-Zapatero; P Chalon; L Kohn; M Dauvrin; J Detollenaere; C Maertens de Noordhout; C Primus-de Jong; I Cleemput; K Van den Heede Journal: Ann Med Date: 2022-12 Impact factor: 5.348
Authors: Pedro J Serrano-Castro; Francisco J Garzón-Maldonado; Ignacio Casado-Naranjo; Angela Ollero-Ortiz; Adolfo Mínguez-Castellanos; Mar Iglesias-Espinosa; Pablo Baena-Palomino; Violeta Sánchez-Sanchez; Rosa María Sánchez-Pérez; José Rubi-Callejon; José Carlos Estévez-María; Benito Galeano-Bilbao; Jesús Romero-Imbroda; Beatriz Sobrino; Carlos Arrabal-Gomez; Begoña Oliver-Martos; Luis Muñoz-Becerra; Nerea Requena; María Del Mar González Álvarez de Sotomayor; Guillermo Estivill-Torrus; Juan Suarez; Nicolas Lundahl Ciano-Petersen; Gracia Pons-Pons; Jose Antonio Reyes-Bueno; Pablo Cabezudo-Garcia; Maria José Aguilar-Castillo; Carlos De la Cruz Cosme; María Duque-Holguera; Eva Cuartero-Rodriguez; Rosa María Vilches-Carrillo; Ismael Carrera-Muñoz; Cristóbal Carnero-Pardo; Teresa Ramirez-Garcia; Juan Manuel Oropesa; Ana Dominguez-Mayoral; Nazaret Pelaez-Viñas; Lucia Valiente; Fernando Rodríguez de Fonseca Journal: Sci Rep Date: 2022-03-03 Impact factor: 4.379